Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-009589

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Ann · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-15 Grant or award : show line 1 in the form Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/wf-form4_165041421126805.xml…